Company intelligence / Profile preview

Many companies

Redwood City, California, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

ManyBio is a biotechnology company focused on the discovery and development of next-generation multi-specific antibody therapeutics. The company utilizes a proprietary platform designed to engineer complex antibody formats with high stability and manufacturability, addressing limitations in current biologics. Their pipeline primarily targets immune checkpoints and other validated oncology pathways to create synergistic therapeutic effects. By leveraging advanced protein engineering, ManyBio aims to provide more effective treatment options for patients with various solid tumors.

Therapeutic areas: Oncology
Modalities: AntibodyBispecific monoclonal antibodyMultispecific antibodyProtein
Industry: Biotech

Beyond the preview

Go deeper on Many companies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Many companies.

Explore the full profile